Web Stats Provided By Google Analytics

Tuesday, November 19, 2013

Obamacare Failure Could Cost US Drug Companies $140 Billion

... the report from Kleinrock's group, which is the research arm of IMS Health, a drug sales analysis company based in Danbury, Connecticut. Drug spending in 2012 was about $328 billion, the group said. Still, global spending on drugs is projected to ...



via Danbury Newswire http://www.Newsmax.com/Newsfront/obamacare-drug-companies-lose/2013/11/19/id/537366

No comments:

Post a Comment

The Raw Danbury Blog And RSS Feed

Popular Posts Danbury Roundup Posts